MYGN Financial Facts

Earnings per diluted share: 0.29
Companion diagnostic services: 7.01M
See Full Income Statement

Total assets: 779.05M
Accounts payable: 17.96M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 8/12/15 *Est. EPS Growth Rate -16.7% *Last Qtr.
Average EPS % Beat Rate -0.2% Revenue Growth Rate +2.2% *Last Qtr.
Average % Move 1-Wk after EPS -7.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/14 Q115 $0.25$0.32 -$0.07$168.8M$175M Details
1/27/11 Q211 $0.26$0.26 $0.00$100.4M$98.84M Details
8/14/12 Q212 $0.34$0.34 $0.00$133M$131.85M = Details
8/9/11 Q411 $0.30$0.29 +$0.01$107.4M$104.43M = Details
11/1/11 Q112 $0.29$0.28 +$0.01$110.5M$106.49M = Details
5/5/15 Q315 $0.40$0.39 +$0.01$180M$183.3M Details
11/2/10 Q111 $0.24$0.23 +$0.01N/AN/A Details
1/31/12 Q212 $0.33$0.31 +$0.02$122.8M$115.28M = Details